2021
Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery
Basu SS, Stopka SA, Abdelmoula WM, Randall EC, Gimenez-Cassina Lopez B, Regan MS, Calligaris D, Lu FF, Norton I, Mallory MA, Santagata S, Dillon DA, Golshan M, Agar NYR. Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery. Npj Breast Cancer 2021, 7: 116. PMID: 34504095, PMCID: PMC8429658, DOI: 10.1038/s41523-021-00318-5.Peer-Reviewed Original ResearchIntraoperative mass spectrometrySurgical marginsBreast cancerTime of surgeryInvasive breast cancerBreast cancer surgeryRegistered clinical trialsBreast cancer tissuesBreast cancer marginsClinical trial analysisPost-surgery analysisSuch resectionsCancer surgerySurgical specimensClinical trialsHistopathological determinationOptimal resectionUninvolved regionsCancer tissuesTumor breastBreast tumorsCandidate biomarkersLipidomic profilesPathological techniquesNormal tissues
2013
Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates: Surgical results from CALGB 40601 (Alliance).
Ollila D, Berry D, Cirrincione C, Carey L, Amos K, Henry N, Winer E, Hudis C, Golshan M. Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates: Surgical results from CALGB 40601 (Alliance). Journal Of Clinical Oncology 2013, 31: 501-501. DOI: 10.1200/jco.2013.31.15_suppl.501.Peer-Reviewed Original ResearchNeoadjuvant therapyBCT candidatesCALGB 40601Neoadjuvant chemotherapySystemic therapySurgical resultsBreast surgeonsBreast cancerTumor-free surgical marginsBreast cancer ptsNeoadjuvant systemic therapyOperable breast cancerBreast conservation ratesPhase III trialsAnti-HER2 treatmentModern systemic therapyBreast cancer operationsBCT eligibilityCancer ptsEligible patientsNeoadjuvant trialsTherapy ratesIII trialsSurgical marginsCancer operations
2011
Surgical Margins and the Risk of Local-Regional Recurrence (LRR) following Mastectomy for Early-stage Breast Cancer
Childs S, Chen Y, Golshan M, Duggan M, Pochebit S, Wong J, Harris J, Bellon J. Surgical Margins and the Risk of Local-Regional Recurrence (LRR) following Mastectomy for Early-stage Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s233-s234. DOI: 10.1016/j.ijrobp.2011.06.436.Peer-Reviewed Original ResearchSurgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer.
Childs S, Chen Y, Pochebit S, Golshan M, Duggan M, Wong J, Harris J, Bellon J. Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer. Journal Of Clinical Oncology 2011, 29: 95-95. DOI: 10.1200/jco.2011.29.27_suppl.95.Peer-Reviewed Original ResearchLocal-regional recurrenceRisk of LRRInvasive diseaseSurgical marginsSuperficial marginsDeep marginBreast cancerEarly-stage breast cancerPositive axillary nodesClose surgical marginsDistant metastasis rateKaplan-Meier methodPost-mastectomy radiationDeep surgical marginsInvasive breast cancerLRR ratePositive nodesAxillary nodesFirst recurrenceLymphovascular invasionPure DCIST3 tumorsConsecutive womenMedian ageMetastasis rate